NCT00142571View on ClinicalTrials.gov

Comparison of Gemcitabine v. Gemcitabine Plus Docetaxel in Unresectable Soft Tissue Sarcoma

PHASE3CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

January 31, 2003

Study Completion Date

September 30, 2007

Conditions
Sarcoma, Soft Tissue
Interventions
DRUG

Gemcitabine

DRUG

Docetaxel

Trial Locations (1)

10021

Memorial Sloan-Kettering Cancer Center, New York

Sponsors

Collaborators (1)

Mayo Clinic
All Listed Sponsors
collaborator

Connective Tissue Oncology Society

OTHER

collaborator

M.D. Anderson Cancer Center

OTHER

collaborator

Massachusetts General Hospital

OTHER

collaborator

Mayo Clinic

OTHER

collaborator

University of Michigan Rogel Cancer Center

OTHER

lead

Memorial Sloan Kettering Cancer Center

OTHER